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Experts of controlled clinical trials argue that decisions on medical interventions should be based on
clinically relevant outcomes and not on surrogates such as laboratory measurements. There are quite a
few examples in which the effect on a surrogate end point substantially diverged from the effect on a
clinically relevant outcome [1,2].
In this respect, the recent paper by Bruno et al. is problematic as it proposed higher vitamin E
intakes for smokers on the basis of greater disappearance rate of ?-tocopherol in the plasma of smokers
[3].  The disappearance rate is a surrogate end point with no validated relation to any clinically relevant
outcome.
In our analyses of the ATBC Study cohort, we found that smoking modifies the effect of 50
mg/day vitamin E supplementation; however, the modification takes place in the direction opposite to that
proposed by Bruno et al. In the ?72-year-old ATBC Study participants who smoked ?15 cigarettes per
day at baseline, vitamin E supplementation increased common cold incidence by 42% (95% CI: +18% to
+70%), whereas in those who smoked less, vitamin E reduced common cold incidence by 29% (95% CI:
?9% to ?46%) [4].
Similarly, smoking modified the effect of vitamin E on pneumonia incidence. In the ATBC Study
participants who had initiated smoking at later age, vitamin E reduced pneumonia incidence in those who
quit smoking during the follow-up by 79% (95% CI: ?40% to ?93%), but had no effect on those who
continued smoking (95% CI: ?47% to +19%) [5].
Thus, in the case of these two respiratory infections, vitamin E supplementation appeared
beneficial for those who were smoking less, but it was harmful or ineffective for those who smoked
heavily at baseline or continued smoking during the follow-up. These findings with clinically relevant
outcomes thus contradict the surrogate-based proposal by Bruno et al. that smokers would benefit of
higher vitamin E intakes and it would seem necessary for them to consume at least 15 mg/day of vitamin
E [3]. Furthermore, the current US RDA recommendation level for vitamin E, 15 mg/day, is not based on
any clinically relevant outcome either and is arbitrary [6]. The divergence in the effects of vitamin E
supplementation in the ATBC Study cohort indicates that caution should be maintained in any proposals
that people should increase their consumption of vitamin E until its effects are better understood.
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